The paternally expressed Peg3 gene in mice encodes an unusual Krü ppel-type zinc finger protein implicated in critical cellular and behavioral functions including growth, apoptosis, and maternal nurturing behavior. Methylation and expression analyses were used to determine whether PEG3 on chromosome 19q13.4 is imprinted in humans. The PEG3 promoter is encompassed within a large CpG-rich region that is differentially methylated in fetal tissues. Furthermore, expression studies demonstrate that PEG3 is ubiquitously imprinted throughout development and postnatally. Multiple isoforms of the PEG3 gene, including a novel transcript, are paternally expressed. These results are the first to show that human chromosome 19q13.4 contains an imprinted region. The imprinted status of PEG3 throughout life coupled with its neural expression and putative roles in regulating cell growth suggests that PEG3 may be a susceptibility locus for cancer as well as neurobehavioral deficits.
INTRODUCTION
Genomic imprinting is a phenomenon thought to have evolved over 100 million years ago as a consequence of interparental genetic conflicts related to growth of offspring (Killian et al., 2000; Moore and Haig, 1991) . Imprinted genes are characterized by the expression of mRNA from a single parental allele, depending on the parent from whom that allele originated. Imprint establishment during gametogenesis and its maintenance in somatic tissues are thought to involve epigenetic marking of chromosomal regions harboring gene regulatory elements. Every imprinted gene analyzed to date is associated with regions of differential methylation. This suggests that the methylation status of the individual parental alleles is important in determining the expression profile of imprinted genes.
Imprinting abnormalities are documented in Angelman syndrome, Beckwith-Wiedemann syndrome, and Prader-Willi syndrome and are suspected to play a role in several other neurobehavioral disorders including autism, bipolar affective disorder, and schizophrenia (Isles and Wilkinson, 2000; Morison and Reeve, 1998; Nicholls, 2000) . Two imprinted genes have also now been shown to dramatically influence the nurturing of offspring in mice. Targeted deletions in the paternally inherited copy of Peg1/Mest (paternally expressed gene 1/mesoderm-specific transcript) on mouse proximal chromosome 6 (Kaneko- Ishino et al., 1995) lead to growth retardation and maternal deficiencies in nest building, pup retrieval, and placentophagia (Lefebvre et al., 1998) . The imprinted gene Peg3 (paternally expressed gene 3) on mouse proximal chromosome 7 functions in several critical cellular activities, including the promotion of cell survival (Relaix et al., 1998) and paradoxically in p53-mediated apoptosis (Relaix et al., 1998 (Relaix et al., , 2000 . Disruption of the paternal copy of mouse Peg3 results in growth impairment, and female mice carrying this mutation are severely compromised in nurturing behavior, frequently resulting in the death of their offspring (Li et al., 1999) .
The ϳ9-kb transcript of PEG3, the human homologue of mouse Peg3, is expressed at highest levels in the ovary, placenta, testis, and brain (Kim et al., 1997) . Recently, a second isoform of the PEG3 gene was identified and named ZIM2 (zinc-finger gene 2 from imprinted domain). It shares the upstream seven exons and transcriptional start site with PEG3, but contains four additional exons downstream from the PEG3 3Ј-UTR, forming an ϳ2.5-kb transcript (Kim et al., 2000a) . This isoform is not present in mice and appears to have marked differences in tissue distribution relative to PEG3, with Northern blots showing expression only in adult testis (Kim et al., 2000a) . Given the presence of multiple PEG3 isoforms and their potential roles in both cell survival and behavior, we have determined the imprinting status of PEG3 in humans.
MATERIALS AND METHODS
Methylation analysis. For methylation analysis of the CpG-rich region flanking the transcription initiation site of PEG3, the CpGenome DNA Modification Kit was used according to the manufacturer's recommendations (Intergen Co., New York, NY). Certain regions of the genome can be resistant to bisulfite treatment due to inefficient denaturation. To alleviate this problem, genomic DNA was first digested with the methylation-insensitive restriction enzyme TaqI before the bisulfite treatment protocol was initiated. One microgram of TaqI-digested genomic DNA isolated from the brain, liver, kidney, and pancreas of an 87-day gestation conceptus was treated with sodium bisulfite to convert unmethylated CpG dinucleotides to UpG pairs, leaving the methylated CpG dinucleotides intact. Titration experiments showed that 100 ng of the treated DNA gave reproducible results when amplified by two rounds of PCR. The resulting products were analyzed by radiolabeled terminator cycle sequencing (USB Corp., Cleveland, OH). Primers were designed to account for complete conversion of unmethylated cytosines by bisulfite treatment and were positioned to amplify sequences between TaqI restriction sites. Primer sequences for analysis of the PEG3 CpG-rich region are available from the authors by request.
Nucleic acid isolation from human tissues. RNA and DNA were extracted from 50 -100 mg of frozen human tissue using RNA STAT-60 following the manufacturer's protocol (Tel-test, Inc., Friendswood, TX) . RNA and DNA from normal adult human ovary were extracted from frozen tissue sections preserved in OCT compound (Tissue-Tek, Torrance, CA). Briefly, the sections were washed in nuclease-free PBS (pH 7.4; Ambion, Austin, TX) followed by pulse spins to pellet the tissue. Nucleic acid was extracted as described above. Tissues from human conceptuses were obtained from the Birth Defects Research Laboratory at the University of Washington. Normal adult human brain tissues were obtained from the Bryan ADRC Autopsy Program of Duke University Medical Center. Normal human ovarian tissue was a kind gift from the laboratory of Dr. A. Berchuck, Department of Obstetrics and Gynecology, Duke University Medical Center.
Analysis of imprinting.
To determine the imprinting status of informative individuals, ϳ2 g of total RNA was first treated with DNase I (Life Technologies, Grand Island, NY) followed by reverse transcription using primer PEG3-12 (primer sequences are listed in Table 1 ) in the presence or absence of reverse transcriptase (Superscript II; Life Technologies), according to the manufacturer's recommendations. Then 0.5 to 4.0 l of the cDNA was used as template for PCR amplification of an 878-bp fragment within exon 9. Human PEG3 gene-specific sequence was amplified with primers PEG3-13 and PEG3-14 using Platinum Taq (Life Technologies; 94°C for 3 min followed by 35 cycles of 94°C for 30 s, 64°C for 30 s, 72°C for 60 s). The products were purified from agarose gels using GenElute spin columns (Sigma, St. Louis, MO) followed by radiolabeled terminator cycle sequencing (USB Corp.) using primer PEG3-15. Specificity of cDNA amplification was confirmed by the absence of RT-PCR products for samples in which the reverse transcriptase was omitted. For imprinting analysis of the ␤ and ␥ isoforms, reverse transcription with primer PEG3␤␥-3 in the presence and absence of reverse transcriptase was followed by two rounds of PCR amplification using primers PEG3␤␥-1 and PEG3␤␥-4 for the first round (94°C for 3 min followed by 35 cycles of 94°C for 30 s, 60°C for 30 s, 72°C for 30 s) and PEG3␤␥-2 and PEG3␤␥-5 for the second round (94°C for 3 min followed by 35 cycles of 94°C for 30 s, 60°C for 30 s, 72°C for 30 s). PCR products were purified using Sigma GenElute columns and sequenced using primer PEG3␤␥-G/A-F in the reverse direction relative to BAC 470f8 (Accession No. AC006115).
RESULTS

Methylation Analysis
One of the hallmarks of imprinted loci in eutherian mammals is the presence of differentially methylated CpG dinucleotides within the context of CpG islands (Reik and Walter, 1998) . The PEG3 promoter region (Fig. 1A) is contained within an ϳ4.8 kb CpG-rich region (WebGene; http://www.itba.mi.cnr.it/webgene). Bisulfite sequencing across this region revealed that all CpG dinucleotides examined were differentially methylated in human fetal brain, kidney, liver, and pancreas (Fig. 1B) . In contrast, a smaller intronic CpGrich region (nucleotide positions 117,965 to 118,702 of Accession No. AC006115) located downstream of PEG3 exon 9 exhibited a mosaic methylation pattern in these same four tissues (data not shown), with fully methylated and fully unmethylated sites interspersed with differentially methylated CpGs. While the function and consequence, if any, of the methylation status of downstream CpG islands are not clear, the finding of clearly differentially methylated CpGs in the PEG3 promoter region indicates that human PEG3 exhibits allele-specific regulation of expression.
PEG3 Expression Analysis
To determine whether PEG3 is monoallelically expressed during fetal development, a single-nucleotide polymorphism was identified within PEG3 exon 9 (G to A transition; frequency 0.39, N ϭ 75) and used for expression analysis. This silent polymorphism corresponds to nucleotide position 138,946 of BAC 470f8 (Accession No. AC006115) that contains the sequence of the entire PEG3 locus. cDNAs containing the poly- morphic site were prepared by reverse transcription of total RNA isolated from tissues of nine informative individuals with gestational ages from 63 to 108 days. The cDNAs were amplified by PCR and analyzed by nucleotide sequencing. Monoallelic expression was found in all tissues in which PEG3 transcripts were produced ( Fig. 2A) , including adrenal gland (N ϭ 6), brain (N ϭ 9), heart (N ϭ 5), kidney (N ϭ 5), lung (N ϭ 6), and placenta (N ϭ 5). Monoallelic PEG3 expression was also found in liver (N ϭ 5), skeletal muscle (N ϭ 3), and gut (N ϭ 3) (data not shown). PEG3 transcripts were not detected in lymphocytes or in umbilical cord tissue.
To determine the parent-of-origin for the expressed PEG3 allele in humans, matched maternal deciduas (N ϭ 4) of informative individuals were genotyped. Figure 2B shows that the maternal decidua for this individual is homozygous for the A allele (A/A) at the polymorphic site within exon 9, while the conceptus is heterozygous at the same site (G/A). RNA derived from total brain of this conceptus showed that only the paternal G allele was expressed. These results were confirmed for three other individuals (data not shown), demonstrating that the human PEG3 is paternally expressed as is the mouse Peg3 gene (Kuroiwa et al., 1996) .
PEG3 Imprinting in Adult Tissues
Genomic imprinting can vary depending on species, tissue, and age of the individual. We therefore established whether human PEG3 maintains imprinting postnatally. DNA from normal adult human brain tissue (N ϭ 12) was screened for informative individuals at the PEG3 polymorphic site. Four informative samples were identified, and the corresponding cDNA was analyzed for imprinting at the PEG3 locus. Figure 3A demonstrates that PEG3 is monoallelically expressed in adult brain. These results were confirmed for the additional three informative samples. Importantly, the finding that PEG3 is imprinted in both fetal and adult brain raises the possibility that if this gene has a role in regulating behavior in humans as it does in mice (Li et al., 1999) , genetic or epigenetic alterations to the single active copy or regulatory region of this gene could lead to behavioral abnormalities.
In humans, ovary and placenta exhibit the highest level of PEG3 expression by Northern blot analysis ( Kim et al., 1997) . To address whether PEG3 is also imprinted postnatally in the ovary, frozen ovarian tissue samples (N ϭ 12) were analyzed for imprint status. Three informative samples demonstrated monoallelic expression of PEG3 (Fig. 3B) . Taken together, these results show that the PEG3 gene is expressed and imprinted in a wide variety of tissues throughout development and adult life.
PEG3 Isoform-Specific Imprint Analysis
The PEG3 locus in humans has recently been shown to encode two isoforms (Kim et al., 2000a) . A schematic representation of the genomic region harboring the PEG3 locus at 19q13.4 is shown in Fig. 4A . These two PEG3 isoforms share the same transcription start site and first seven exons, but then diverge such that PEG3 (hereafter referred to as PEG3␣) contains two additional exons while the second isoform, named ZIM2 (Accession No. AF166122, derived from testis; hereafter referred to as PEG3␤), also encodes a zinc finger protein with four additional exons located approximately 20 kb downstream from the 3Ј-UTR of PEG3␣. Despite sharing transcription start sites and putative regulatory elements, expression analysis revealed differences in tissue distribution. While PEG3␣ is most highly expressed in ovary, testis, placenta, and brain (Kim et al., 1997) , PEG3␤ transcripts are most readily detected in adult testis (Kim et al., 2000a) . It was therefore important to determine whether the ␤ isoform of PEG3 is also imprinted.
A systematic search of the 3Ј-UTR and PEG3␤-specific exons led to the discovery of a single-nucleotide polymorphism within exon 12 of the ␤ isoform, at the complement of BAC 470f8 position 104,837 (silent T to C transition; frequency 0.27, N ϭ 33; Fig. 4A ). However, when cDNAs containing this polymorphic site were generated and amplified, the products obtained differed in size and number depending on the tissue type from which they originated (data not shown). Further sequence analysis of these PCR products revealed the presence of a previously unidentified, 72-nucleotide exon of the PEG3␤ transcription unit (exon 11 in Fig. 
FIG. 2. PEG3 imprinting in human fetal tissues. (A) Expression analysis of PEG3
RT-PCR products that include the polymorphic site within exon 9 from tissues of a 63-day conceptus. Nucleotide sequence analysis of genomic DNA indicates that this individual is informative (A/G) at the polymorphic site. cDNAs from adrenal gland, brain, heart, kidney, lung, and placenta of this same individual show that the G allele is not expressed (arrowhead), demonstrating monoallelic PEG3 RNA expression. (B) Schematic pedigree for an 80-day gestation conceptus. Matched maternal decidua is homozygous for the A allele (upper left "DNA" panel) for this informative (G/A) conceptus (bottom left "DNA" panel) showing that the G allele of the conceptus was contributed paternally. cDNA from the brain of the conceptus (bottom right) is derived from the G allele only (arrowhead marks the absence of the A allele), demonstrating that PEG3 is paternally expressed. 4A), which was present in most tissues examined with the notable exception of heart and placenta. This exon is flanked by GT/AG consensus splice sites (Breathnach and Chambon, 1981) but harbors a stop codon in-frame with the PEG3␤ coding sequence. For heart and placenta, only PEG3␤ transcripts were present while both PEG3␤ and transcripts containing exon 11 (hereafter referred to as PEG3␥) were present in adrenal gland, brain, kidney, liver, lung, and skeletal muscle.
To investigate the imprinting status of the PEG3␤ and PEG3␥ isoforms, cDNAs were prepared from available tissues of informative individuals. Since transcripts of both PEG3␤ and PEG3␥ contain exon 12, the single-nucleotide polymorphism located in this exon is useful for revealing the imprint status of both isoforms. Monoallelic expression was found for both isoforms in all tissues examined (Fig. 4B ) including adrenal gland (N ϭ 2), brain (N ϭ 5), heart (N ϭ 4), kidney (N ϭ 2), lung (N ϭ 2), and placenta (N ϭ 1), as well as skeletal muscle (N ϭ 1; data not shown). These results demonstrate that both PEG3␤ and PEG3␥ isoforms are expressed from the same parental allele since the primers used in this set of experiments do not discriminate between the isoforms.
The human and mouse PEG3 sequences share a high degree of homology (Kim et al., 2000a) . Mice express another imprinted zinc finger gene, Zim1, ϳ7 kb downstream from Peg3 (Kim et al., 1999) and in the same transcriptional orientation relative to Peg3 (Kim et al., 
FIG. 4. Multiple human PEG3 isoforms are imprinted. (A)
Genomic organization of the PEG3 locus. PEG3␣ includes exons 1-9 while PEG3␤ (ZIM2) (Kim et al., 2000a) contains exons 1-7, 10, and 12-14. PEG3␥ is identical to PEG3␤ except for the addition of exon 11, which has a consensus splice donor and acceptor site (shown below) but contains an in-frame stop codon (*). Numbers correspond to the reverse complement of positions within BAC 470f8 (Accession No. AC006115). The CpG-rich region is shown as a cross-hatched oval, and the arrow at exon 12 indicates the position of the polymorphism used to analyze imprinting of PEG3␤ and PEG3␥. (B) Nucleotide sequence analysis of the PEG3␤ and ␥ isoforms from multiple tissues of an informative 78-day gestation conceptus. This individual is informative for the C/T polymorphism at the DNA level (arrow), but cDNAs from all analyzed tissues demonstrate a lack of expression of the T allele (arrowheads).
2000a). Zim1 in mice and the PEG3␤-specific sequence in humans do not appear to encode homologous genes, as they share only 30% amino acid identity (Kim et al., 2000a) . Furthermore, Zim1 is reported to be maternally expressed and paternally imprinted, which is opposite of Peg3 (Kim et al., 1999) . Nonetheless, it is still possible that Zim1 and PEG3␤ are evolutionarily related and might have similar maternal expression patterns, so we also determined the parent-of-origin for expression of the PEG3␤ and PEG3␥ isoforms. We found that maternal decidua matched to the informative conceptus in Fig. 4B was homozygous for the T allele (data not shown) while the conceptus exhibited expression exclusively from the C allele (Fig. 4B) , demonstrating that both the ␤ and the ␥ isoforms of the PEG3 locus are paternally expressed. Thus, our results support the contention that PEG3␤ and mouse Zim1 are not homologues (Kim et al., 2000a) .
DISCUSSION
Genomic imprinting is a phenomenon that is becoming increasingly relevant to studies of behavioral disorders in humans (Isles and Wilkinson, 2000) . A distinguishing feature of imprinted genes is that their functionally haploid state leads to a heightened susceptibility to both epigenetic and genetic mutations. Targeted imprinted gene deletion studies in mice have shown a diverse array of neurodevelopmental abnormalities, from memory and learning deficits to severe impairments in nurturing behaviors (Isles and Wilkinson, 2000) . Because of the personal and social importance of neurobehavioral defects in humans, we investigated the imprint status of PEG3, the human homologue of a gene known to be involved in maternal nurturing behavior in mice (Li et al., 1999) . Herein, we report that PEG3 is imprinted throughout human development in a number of tissues including the brain.
One of the common characteristics shared among all imprinted genes identified to date is their association with CpG islands that demonstrate parental-specific methylation patterns. Allele-specific methylation is thought to be a fundamental component of imprinted gene expression and is established differentially in the gametes prior to fertilization. The epigenetic regulation of imprinted gene expression most likely includes other chromatin-associated proteins, such as histone deacetylases, which are proposed to function synergistically with methylation to repress transcription (Hu et al., 1998; Pedone et al., 1999) . We have demonstrated in this study that the PEG3 promoter region is extensively differentially methylated in multiple tissue types. This finding is consistent with the idea that promoter region differential methylation is a major contributing factor to the monoallelic expression of this gene.
PEG3 belongs to the family of Krü ppel-type zinc finger proteins, the members of which are generally thought to act as transcription factors. While both the PEG3␣ and ␤ isoforms encode Krü ppel-type zinc finger proteins, the PEG3␥ isoform is predicted to transcribe a truncated protein that lacks a zinc finger region. Since PEG3␥ is not present in fetal heart or placenta, it suggests that this isoform has a required function in those tissues where it is expressed concomitantly with PEG3␣ and PEG3␤ (i.e., adrenal gland, brain, kidney, liver, lung, and skeletal muscle). Alternatively spliced exons harboring stop codons can lead to translation of functionally relevant protein products (Gervois et al., 1999; Kirschner et al., 1999) . The ␥ isoform may serve as a regulator of protein function by inhibiting homologous and/or heterologous interaction of PEG3␣ or PEG3␤ with their constituent cellular target(s) (Ross et al., 1997) or by altering the subcellular localization of these proteins (Kirschner et al., 1999) . Although to date only a single Peg3 transcript in mice has been characterized, evidence suggests that multiple isoforms of Peg3 may also exist since RNAs larger than the ϳ9-kb Peg3 transcript have been detected (Kim et al., 1997) . Further research will be required to understand the potential interplay, if any between the different isoforms of PEG3.
Imprinted genes tend to be organized in clusters within the genome, such as those positioned at human chromosomes 11p15.5 and 15q11-q13 (Morison and Reeve, 1998) . PEG1/MEST and ␥2-COP have also recently been shown to form an imprinted domain on human chromosome 7q32 (Blagitko et al., 1999) . It is currently unclear whether human chromosome 19q13.4 also contains such a cluster of imprinted genes. The orthologous Peg3 gene on mouse proximal chromosome 7 is flanked by the maternally expressed gene Zim1 (Kim et al., 1999) and two recently described paternally expressed genes: Ocat (ossification center-associated transcript) and Usp29 (ubiquitin-specific processing protease 29) (Kim et al., 2000b) . Despite the lack of a Zim1 orthologue in humans (Kim et al., 2000a) , there is some evidence for the presence of an imprinted cluster at 19q13.4 since Ocat-like sequences have been identified near the transcription start site of PEG3 and USP29 sequences are located approximately 400 kb upstream from PEG3 (Kim et al., 2000b) . Further analyses in humans will be required to determine whether additional imprinted genes are present at chromosome 19q13.4.
The 19q13.2-q13.4 region in humans has been linked not only to familial hydatidiform moles (Moglabey et al., 1999) , but also ovarian cancer (Bicher et al., 1997; Pejovic, 1995) and gliomas (Rubio et al., 1994) . There are no reported cases in humans of either maternal or paternal uniparental disomies for chromosome 19 (Ledbetter and Engel, 1995) and only limited reports of partial trisomy for chromosome 19q (Bhat et al., 2000; Tercanli et al., 2000 , and references therein). Individuals having chromosome 19q partial trisomies are characterized by low birth weight, growth retardation, psychomotor retardation, down-turned mouth, flat facies, abnormal ears, and a short neck with excess skin folds (Bhat et al., 2000) . Mice with maternal duplications of the homologous region on proximal chromosome 7 exhibit neonatal lethality (Kelsey and Reik, 1998) , which together with the human data indicates a stringent requirement for an imprinted gene(s) present in this region. The imprinted status of multiple PEG3 isoforms suggests that this locus may contribute to anomalies associated with chromosome 19q, especially in light of the increased potential for gene disregulation by promoter CpG island hypermethylation events associated with both normal aging and carcinogenesis (for reviews, see Issa, 2000, and Herman and Baylin, 2000) . Alterations in DNA methylation patterns for several imprinted genes have been associated with either abnormal biallelic expression (a loss of imprinting) or transcriptional silencing (a gain of imprinting) in multiple human disorders and diseases. However, the contribution of these methylation changes to the etiology of these disorders has not been conclusively determined, despite accumulating evidence. Although our studies have not demonstrated the parental origin for the methylated PEG3 allele, it is likely that the methylated allele is maternal, as it is in mice . Therefore, epigenetic alterations affecting a single PEG3 allele could lead to heritable silencing or overexpression of the PEG3 isoforms. The occurrence, mechanism, and consequences of such alterations at the PEG3 locus have yet to be investigated.
Peg3 has a demonstrated role in maternal nurturing behavior in mice as disruptions in the paternally inherited allele lead to defective nurturing of pups (Li et al., 1999) . It is not clear whether other types of behavioral deficits extend to males inheriting a mutant paternal Peg3 allele since the original report did not assess this aspect of Peg3 function. Expression of PEG3 in the brains of both humans and mice (Kim et al., 1997 ), together with a high level of sequence similarity (Kim et al., 1997 (Kim et al., , 2000b , suggests that this protein may share a conserved function in both species. If PEG3 has the same behavioral effects in humans as it does in mice, disruption of the paternally inherited copy of PEG3 could potentially lead to deleterious consequences related to nurturing behavior.
In conclusion, we have shown that multiple isoforms of PEG3 are imprinted in a number of tissues throughout development, providing the first evidence of genomic imprinting on human chromosome 19. Imprinted expression of the PEG3 isoforms is accompanied by differential methylation of CpG dinucleotides throughout the promoter region, consistent with DNA methylation being involved in the establishment and maintenance of imprinting. These findings provide further impetus to investigate the involvement of PEG3 not only in cancer but also in human behavioral disorders.
